| UniProt ID | CLIC1_HUMAN | |
|---|---|---|
| UniProt AC | O00299 | |
| Protein Name | Chloride intracellular channel protein 1 | |
| Gene Name | CLIC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 241 | |
| Subcellular Localization |
Nucleus. Nucleus membrane Single-pass membrane protein . Cytoplasm. Cell membrane Single-pass membrane protein . Mostly in the nucleus including in the nuclear membrane. Small amount in the cytoplasm and the plasma membrane. Exists both as solubl |
|
| Protein Description | Can insert into membranes and form chloride ion channels. Channel activity depends on the pH. Membrane insertion seems to be redox-regulated and may occur only under oxydizing conditions. Involved in regulation of the cell cycle.. | |
| Protein Sequence | MAEEQPQVELFVKAGSDGAKIGNCPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAEEQPQVE ------CCCCCCCEE | 29.09 | 22223895 | |
| 13 | Acetylation | PQVELFVKAGSDGAK CCEEEEEEECCCCCE | 39.43 | 19608861 | |
| 20 | Acetylation | KAGSDGAKIGNCPFS EECCCCCEECCCCHH | 57.59 | 26051181 | |
| 20 | Ubiquitination | KAGSDGAKIGNCPFS EECCCCCEECCCCHH | 57.59 | 21906983 | |
| 24 | S-glutathionyl cysteine | DGAKIGNCPFSQRLF CCCEECCCCHHHHHH | 2.80 | - | |
| 24 | S-nitrosylation | DGAKIGNCPFSQRLF CCCEECCCCHHHHHH | 2.80 | 24105792 | |
| 24 | Glutathionylation | DGAKIGNCPFSQRLF CCCEECCCCHHHHHH | 2.80 | 16286078 | |
| 24 | S-palmitoylation | DGAKIGNCPFSQRLF CCCEECCCCHHHHHH | 2.80 | 29575903 | |
| 44 | Phosphorylation | KGVTFNVTTVDTKRR HCCEEEEEECCCCCC | 23.39 | 23186163 | |
| 45 | Phosphorylation | GVTFNVTTVDTKRRT CCEEEEEECCCCCCC | 16.47 | 23186163 | |
| 48 | Phosphorylation | FNVTTVDTKRRTETV EEEEECCCCCCCHHH | 23.32 | 22199227 | |
| 49 | Acetylation | NVTTVDTKRRTETVQ EEEECCCCCCCHHHH | 35.10 | 23954790 | |
| 49 | Ubiquitination | NVTTVDTKRRTETVQ EEEECCCCCCCHHHH | 35.10 | 21890473 | |
| 49 | Malonylation | NVTTVDTKRRTETVQ EEEECCCCCCCHHHH | 35.10 | 26320211 | |
| 52 | Phosphorylation | TVDTKRRTETVQKLC ECCCCCCCHHHHHHC | 39.79 | 20068231 | |
| 57 | Ubiquitination | RRTETVQKLCPGGQL CCCHHHHHHCCCCCC | 47.96 | 21906983 | |
| 59 | S-nitrosylation | TETVQKLCPGGQLPF CHHHHHHCCCCCCCE | 3.66 | 24105792 | |
| 95 | Ubiquitination | LCPPRYPKLAALNPE HCCCCCCCHHHCCCC | 41.65 | - | |
| 95 | Acetylation | LCPPRYPKLAALNPE HCCCCCCCHHHCCCC | 41.65 | 25953088 | |
| 103 | Phosphorylation | LAALNPESNTAGLDI HHHCCCCCCCCCHHH | 40.51 | 22817900 | |
| 105 | Phosphorylation | ALNPESNTAGLDIFA HCCCCCCCCCHHHHH | 31.23 | 21601212 | |
| 113 | Ubiquitination | AGLDIFAKFSAYIKN CCHHHHHHHHHHHHC | 29.15 | 21906983 | |
| 115 | Phosphorylation | LDIFAKFSAYIKNSN HHHHHHHHHHHHCCC | 21.32 | 28258704 | |
| 117 | Phosphorylation | IFAKFSAYIKNSNPA HHHHHHHHHHCCCHH | 15.95 | 28258704 | |
| 119 | Acetylation | AKFSAYIKNSNPALN HHHHHHHHCCCHHHC | 41.46 | 19608861 | |
| 119 | Ubiquitination | AKFSAYIKNSNPALN HHHHHHHHCCCHHHC | 41.46 | 21890473 | |
| 119 | Malonylation | AKFSAYIKNSNPALN HHHHHHHHCCCHHHC | 41.46 | 26320211 | |
| 121 | Phosphorylation | FSAYIKNSNPALNDN HHHHHHCCCHHHCCC | 38.91 | 25159151 | |
| 131 | Acetylation | ALNDNLEKGLLKALK HHCCCHHHHHHHHHH | 59.01 | 19608861 | |
| 131 | Ubiquitination | ALNDNLEKGLLKALK HHCCCHHHHHHHHHH | 59.01 | 21890473 | |
| 131 | Malonylation | ALNDNLEKGLLKALK HHCCCHHHHHHHHHH | 59.01 | 26320211 | |
| 135 | Malonylation | NLEKGLLKALKVLDN CHHHHHHHHHHHHHH | 57.63 | 26320211 | |
| 135 | Acetylation | NLEKGLLKALKVLDN CHHHHHHHHHHHHHH | 57.63 | 23749302 | |
| 135 | Ubiquitination | NLEKGLLKALKVLDN CHHHHHHHHHHHHHH | 57.63 | 21890473 | |
| 138 | Acetylation | KGLLKALKVLDNYLT HHHHHHHHHHHHHHC | 45.68 | 25953088 | |
| 138 | Ubiquitination | KGLLKALKVLDNYLT HHHHHHHHHHHHHHC | 45.68 | 21906983 | |
| 143 | Phosphorylation | ALKVLDNYLTSPLPE HHHHHHHHHCCCCCH | 15.83 | 23403867 | |
| 145 | Phosphorylation | KVLDNYLTSPLPEEV HHHHHHHCCCCCHHC | 20.24 | 23403867 | |
| 146 | Phosphorylation | VLDNYLTSPLPEEVD HHHHHHCCCCCHHCC | 23.11 | 28176443 | |
| 155 | Phosphorylation | LPEEVDETSAEDEGV CCHHCCCCCCCCCCC | 28.86 | 25159151 | |
| 156 | Phosphorylation | PEEVDETSAEDEGVS CHHCCCCCCCCCCCC | 27.84 | 28355574 | |
| 163 | Phosphorylation | SAEDEGVSQRKFLDG CCCCCCCCCCCCCCC | 34.81 | 25159151 | |
| 166 | Ubiquitination | DEGVSQRKFLDGNEL CCCCCCCCCCCCCCE | 42.51 | 21890473 | |
| 166 | Acetylation | DEGVSQRKFLDGNEL CCCCCCCCCCCCCCE | 42.51 | 23954790 | |
| 178 | S-nitrosylation | NELTLADCNLLPKLH CCEEHHHCCCCCCCE | 3.00 | 24105792 | |
| 178 | S-palmitoylation | NELTLADCNLLPKLH CCEEHHHCCCCCCCE | 3.00 | 26865113 | |
| 183 | Ubiquitination | ADCNLLPKLHIVQVV HHCCCCCCCEEEEHH | 53.30 | - | |
| 183 | Acetylation | ADCNLLPKLHIVQVV HHCCCCCCCEEEEHH | 53.30 | 23749302 | |
| 191 | S-palmitoylation | LHIVQVVCKKYRGFT CEEEEHHHHHHCCCC | 3.10 | 29575903 | |
| 191 | S-nitrosocysteine | LHIVQVVCKKYRGFT CEEEEHHHHHHCCCC | 3.10 | - | |
| 191 | S-nitrosylation | LHIVQVVCKKYRGFT CEEEEHHHHHHCCCC | 3.10 | 20140087 | |
| 192 | Ubiquitination | HIVQVVCKKYRGFTI EEEEHHHHHHCCCCC | 41.03 | - | |
| 192 | Acetylation | HIVQVVCKKYRGFTI EEEEHHHHHHCCCCC | 41.03 | 25953088 | |
| 193 | Ubiquitination | IVQVVCKKYRGFTIP EEEHHHHHHCCCCCC | 34.74 | - | |
| 195 | Methylation | QVVCKKYRGFTIPEA EHHHHHHCCCCCCHH | 42.50 | - | |
| 198 | Phosphorylation | CKKYRGFTIPEAFRG HHHHCCCCCCHHHHH | 38.15 | 21712546 | |
| 204 | Methylation | FTIPEAFRGVHRYLS CCCCHHHHHHHHHHH | 53.96 | - | |
| 209 | Phosphorylation | AFRGVHRYLSNAYAR HHHHHHHHHHHHHHH | 10.29 | 23186163 | |
| 211 | Phosphorylation | RGVHRYLSNAYAREE HHHHHHHHHHHHHHH | 15.52 | 27499020 | |
| 214 | Phosphorylation | HRYLSNAYAREEFAS HHHHHHHHHHHHHHH | 15.50 | 23312004 | |
| 221 | Phosphorylation | YAREEFASTCPDDEE HHHHHHHHHCCCHHH | 35.54 | 28102081 | |
| 222 | Phosphorylation | AREEFASTCPDDEEI HHHHHHHHCCCHHHH | 25.32 | 20873877 | |
| 223 | S-palmitoylation | REEFASTCPDDEEIE HHHHHHHCCCHHHHH | 3.01 | 29575903 | |
| 223 | Glutathionylation | REEFASTCPDDEEIE HHHHHHHCCCHHHHH | 3.01 | 22555962 | |
| 233 | Phosphorylation | DEEIELAYEQVAKAL HHHHHHHHHHHHHHH | 21.37 | 28796482 | |
| 238 | Ubiquitination | LAYEQVAKALK---- HHHHHHHHHHC---- | 56.23 | - | |
| 241 | Ubiquitination | EQVAKALK------- HHHHHHHC------- | 64.25 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLIC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLIC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLIC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LSM1_HUMAN | LSM1 | physical | 14667819 | |
| AKAP9_HUMAN | AKAP9 | physical | 12163479 | |
| CPT1A_HUMAN | CPT1A | physical | 21988832 | |
| NTF4_HUMAN | NTF4 | physical | 21988832 | |
| RLA1_HUMAN | RPLP1 | physical | 21988832 | |
| THA_HUMAN | THRA | physical | 21988832 | |
| ZN184_HUMAN | ZNF184 | physical | 21988832 | |
| NEMO_HUMAN | IKBKG | physical | 21988832 | |
| PRDX4_HUMAN | PRDX4 | physical | 21988832 | |
| NUP62_HUMAN | NUP62 | physical | 21988832 | |
| ZN302_HUMAN | ZNF302 | physical | 21988832 | |
| DDB1_HUMAN | DDB1 | physical | 26344197 | |
| SPS1_HUMAN | SEPHS1 | physical | 26344197 | |
| TPRN_HUMAN | TPRN | physical | 28514442 | |
| PRSR2_HUMAN | PROSER2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-119; LYS-131 ANDLYS-135, AND MASS SPECTROMETRY. | |